Assembly Biosciences ASMB Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's deferred tax assets and other non-current assets?
- Assembly Biosciences (ASMB) reported deferred tax assets and other non-current assets of $312K in Q1 2026.
- How has Assembly Biosciences's deferred tax assets and other non-current assets changed year-over-year?
- Assembly Biosciences's deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $312K to $312K.
- What is the long-term trend for Assembly Biosciences's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Assembly Biosciences's deferred tax assets and other non-current assets has grown at a -45.3% compound annual growth rate (CAGR), from $6.39M to $312K.